Vapotherm, the medical equipment manufacturer in Exeter, last week received a delisting warning because from the New York Stock Exchange for not meeting capital and equity requirements, The notice ...
EXETER, N.H., Dec. 14, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced it has received notice that the New York Stock Exchange ("NYSE") has determined ...
Vapotherm Inc. has received a second delisting notice from the New York Stock Exchange, this time because its stock price hadn’t risen above a dollar for 30 consecutive days. Ironically, the notice ...
Exeter, New Hampshire-based medical technology company Vapotherm has secured up to US$52 million in debt financing through a combination of a term loan facility and a revolving credit facility. The ...
Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, ...
Vapotherm, Inc. VAPO was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal ...
Vapotherm press release (NYSE:VAPO): Q2 GAAP EPS of -$0.29 beats by $0.07. Revenue of $16M (+23.1% Y/Y) misses by $1M. The Company’s unrestricted cash balance was $18.0 million at the end of the ...
Alger Mid Cap Focus Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here. Class Z shares of the Alger Mid Cap Focus Fund outperformed the Russell Midcap Growth ...
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...
EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO) today announced that it has received the CE Mark for its Vapotherm Oxygen Assist Module (OAM). When used with a Precision Flow® system, the ...
For fiscal year 2021, the Company now expects revenue of at least $102 million, which reflects an increase of $17 million over the low end of our previously announced revenue guidance of $85 million ...
The company released its fiscal first-quarter results. During the first quarter, Vapotherm’s revenue was $19.1 million, a 55.4% year-over-year increase. It came in slightly ahead of the $18.9 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback